FIELD: pharmacology.
SUBSTANCE: invention relates to application of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborol, or its pharmaceutically acceptable salts for manufacture of a drug to treat or prevent diseases associated with inflammation, selected from acne and lupus in humans.
EFFECT: application of this substance allows to treat skin diseases associated with an autoimmune component.
3 dwg, 20 ex
Title | Year | Author | Number |
---|---|---|---|
BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2508113C2 |
BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2009 |
|
RU2547441C2 |
BORON-CONTAINING SMALL MOLECULES | 2006 |
|
RU2606947C2 |
BORON-CONTAINING SMALL MOLLECULES | 2006 |
|
RU2414906C2 |
P38 KINASE-INHIBITING AGENTS | 2010 |
|
RU2532376C2 |
1-THIO-D-GLUCITOL DERIVATIVES | 2006 |
|
RU2387649C2 |
BENZOINDAZOLONE COMPOUND AND INTERMEDIATE THEREOF | 2020 |
|
RU2782882C1 |
NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
TRIAZOLES USED AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2393155C2 |
Authors
Dates
2018-01-25—Published
2007-02-16—Filed